lung cancer Archives

VisionGate acquires exclusive rights to Iloprost

cancer

VisionGate, Inc., a biotech company in the early lung cancer detection space, announced, Thursday, it acquired exclusive rights to the University of Colorado’s patent for the use of the drug Iloprost in the prevention of lung cancer. This makes VisionGate one of the first companies to evolve from a diagnostic company to a diagnostic and… Read More →

Renowned surgeon joins VisionGate advisory board

cancer

VisionGate, Inc. a company that has developed a non-invasive test for the early detection of lung cancer, LuCED, announced that nationally renowned thoracic surgeon Dr. Harvey Pass has joined its Medical Advisory Board. Dr. Pass specializes in detecting, diagnosing and treating pleural mesothelioma and lung cancer. He is also a renowned cancer researcher widely known… Read More →

Dignity Health in Arizona invests in VisionGate

cancer

VisionGate has received financial backing from Dignity Health in Arizona for development of a revolutionary, non-invasive test for the early detection of lung cancer, the world’s deadliest cancer. Patient sputum samples are processed on the company’s patented Cell-CT® system – aptly named because it takes an optical CT scan of individual cells to generate digital,… Read More →

TGen finds clue to stop spread of lung cancer

cancer

Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute (TGen). The hepatocyte growth factor receptor (HGFR/MET) and fibroblast growth factor-inducible 14 (FN14) are proteins associated with the potential spread of non-small… Read More →

TGen identifies key lung cancer enabler

cancer

Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments. Non-small cell lung cancer (NSCLC) makes up about 85 percent of the nearly 160,000 Americans expected to die this year from lung cancer,… Read More →